ClinicalTrials.gg
Not yet recruitingNCT07667179Updated Jun 24, 2026

NAVO:J School-Based Group Intervention for Adolescent Mental Health

An interventional study of NAVO:J (digital mental health platform) in Resilience and Depression, sponsored by Ajou University School of Medicine. Not yet recruiting at 1 site in South Korea. Open to participants aged 7 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Ajou University School of Medicine · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Not applicable
Ages
7 Years to 19 Years
Sex
All
01

Study summary

The purpose of this study is to determine and verify whether a school-based group intervention using the digital mental health platform NAVO:J can effectively improve the mental health of adolescents-particularly reducing depression, anxiety, and stress while enhancing resilience.

Read the detailed description

NAVO:J is a digital mental health platform designed to promote adolescent mental health.

The intervention will be conducted as a single-group pre-post design with students (N = 250 subjects) who apply for the Level 2-2 (group intervention) program.

The intervention period will be 17 weeks (17 sessions, once a week for about 40 minutes), with a mid-point evaluation at week 8 and a post-intervention evaluation at week 17.

02

Conditions studied

  • Resilience
  • Depression

Browse trials for

03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 250 is above the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Ajou University School of Medicine is the lead sponsor of 173 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students who apply for the group intervention program
  • Possession of an internet-enabled smartphone
  • Consent to study participation by both the participant and their legal guardian

Exclusion criteria

Exclusion Criteria:

  • Inability to install or run "NAVO:J" on the participant's smartphone
  • Current participation in another interventional study
  • A medical condition severe enough to preclude the intervention or outcome assessment
  • Judged by the researcher to be unlikely to participate cooperatively through the end of the study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    NAVO:J Intervention Group

    Participants in this single-arm group use the digital mental health platform NAVO:J for 17 weeks (17 sessions, once a week for approximately 40 minutes). Each session includes app-based activities such as recommended mental health videos, tailored self-care solutions, self-assessments, mind coaching, and diary entries. Mental health outcomes are assessed at baseline, mid-point (week 8), and post-intervention (week 17) using a single-group pre-post design.

    Behavioral: NAVO:J (digital mental health platform)

Interventions

  • BehavioralNAVO:J (digital mental health platform)

    Participants use NAVO:J, a digital mental health platform developed for adolescents, delivered as a structured group intervention over 17 weeks (17 sessions, once weekly, approximately 40 minutes each). The platform provides algorithm-based recommended videos, 12 tailored "mind solutions" based on emotional-behavioral characteristics, self-assessments (personality, depression, anxiety, stress, self-esteem, smartphone use), expert-supported community features, mind coaching, growth tracking across 10 adolescent mental health indicators, and a mood diary. Sessions are facilitated weekly by trained researchers following a standardized manual.

06

What researchers measure

Primary outcomes

  1. Change in Depression (PHQ-9)

    Depression is measured using the Korean version of the Patient Health Questionnaire-9 (PHQ-9), based on the DSM-IV criteria for major depressive disorder, assessing symptoms experienced over the past two weeks. The scale consists of 9 items rated on a 4-point Likert scale (score range: 0-27). Higher scores indicate more severe depressive symptoms. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  2. Change in Resilience (CD-RISC-10)

    Resilience is measured using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10), a self-report measure of an individual's ability to recover and adapt under adversity or stress. Each item is rated on a 5-point Likert scale (score range: 0-40). Higher scores indicate greater resilience. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

Secondary outcomes

  1. Change in Maum-EASY Anxiety and Depression Problems

    The Maum-EASY Test is a self-report screening tool developed to detect students' mental health problems early and prevent worsening. The anxiety and depression subscale measures the level of anxiety- and depression-related problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of such problems (score range: 0-24). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  2. Change in Maum-EASY Suicide and Crisis Problems

    The suicide and crisis subscale of the Maum-EASY Test measures the level of serious risk symptoms such as suicidality and severe psychological problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater need for priority attention and intervention (score range: 0-18). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  3. Change in Maum-EASY Externalizing Problems

    The externalizing subscale of the Maum-EASY Test measures the level of outwardly expressed behavioral problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as oppositional behavior, delinquency, and habitual lying (score range: 0-24). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  4. Change in Maum-EASY Psychological Trauma Problems

    The psychological trauma subscale of the Maum-EASY Test measures the presence of traumatic experiences and related problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as intrusive memories, avoidance of others, and distrust of others (score range: 0-21). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  5. Change in Maum-EASY School Life Adjustment

    The school life adjustment subscale of the Maum-EASY Test measures difficulties related to school adjustment and reduced coping skills, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as lack of confidence, maladaptive coping, and difficulty making friends (score range: 0-21). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  6. Change in Subjective Mental Health (VAS)

    Subjective mental health is measured using a self-report Visual Analog Scale (VAS) developed by the research team to multidimensionally assess adolescents' perceived mental health. It consists of 9 items, each rated on an 11-point scale from 0 (not at all) to 10 (very much). It is used as a supplementary measure of overall perceived mental health. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  7. Change in Empathy Quotient (K-EQ)

    Empathy is measured using the Korean version of the Empathy Quotient (K-EQ), which assesses multidimensional empathic ability across cognitive empathy, emotional empathy, and social skills. It consists of 17 items rated on a 4-point Likert scale (score range: 17-68). Higher scores indicate greater empathic ability. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  8. Change in Grit (GRIT-S)

    Grit is measured using the Short Grit Scale (GRIT-S), comprising two subfactors: consistency of effort and consistency of interest. It consists of 8 items rated on a 5-point Likert scale (score range: 6-30). Higher scores indicate greater grit. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

Other outcomes

  1. Change in Big Five Personality Traits (BFI-K-10)

    Personality is measured using a 15-item short form of the Big Five Inventory, comprising five subfactors: neuroticism, extraversion, openness, agreeableness, and conscientiousness. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree) (score range: 15-75). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

  2. NAVO:J App Log Data (Adherence)

    Objective adherence is assessed using NAVO:J platform log data, including app access time and the scope of activities completed during the study period. This measure is used to verify participant compliance with the intervention.

    Time frame: Throughout the intervention period (week 1 to week 17)

  3. Self-Reported Adherence Questionnaire

    Subjective adherence is assessed using a self-report questionnaire on the number and duration of app sessions during the study period, administered at the post-intervention assessment.

    Time frame: Week 17 (post-intervention)

  4. Smartphone App Satisfaction Questionnaire

    App satisfaction is assessed using a self-report questionnaire evaluating ease of use, information reliability and quality, perceived improvement in mental health, and overall satisfaction, administered at the post-intervention assessment.

    Time frame: Week 17 (post-intervention)

07

Study locations

1 site
  • Ajou Medical University
    Suwon, 16499, South Korea
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07667179
Responsible party
Chang Hyung Hong (Principal Investigator, Ajou University School of Medicine) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 24, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Jun 24, 2026

Study contacts

Yong Hyuk Choi
Contact
brainist.cho@gmail.com
+82-31-219-5182
Anna You
Contact
uanna@ajou.ac.kr
+82-31-219-4696
Chang Hyung Hong
principal investigator · Ajou Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion